Exosomes-carrying Epstein-Barr virus-encoded small RNA-1 induces indoleamine 2, 3-dioxygenase expression in tumor-infiltrating macrophages of oral squamous-cell carcinomas and suppresses T-cell activity by activating RIG-I/IL-6/TNF-α pathway

Oral Oncol. 2021 Jun:117:105279. doi: 10.1016/j.oraloncology.2021.105279. Epub 2021 Apr 2.

Abstract

Objectives: Although exosomes carrying Epstein-Barr virus-encoded small RNA-1 (EBER-1) are involved in the immunosuppressive tumor microenvironments of EBV-associated head and neck carcinomas, the effects of EBER-1-associated exosomes on tumor-infiltrating macrophages are poorly understood.

Materials and methods: The association between EBV infection and expression of indoleamine 2,3-dioxygenase (IDO) was assessed in 165 paraffin-embedded oral squamous cell carcinoma (OSCC) tissue samples. Using in vitro techniques, we investigated whether stimulation of the RIG-I/IL-6/TNF-α pathway by exosomes carrying EBER-1 is critical for IDO induction in macrophages. We performed a thymidine incorporation and a cell cytolytic assay to test for up-regulated IDO in macrophages that can block the proliferation and function of effector T cells.

Results: Some infiltrated macrophages expressed levels of IDO higher than OSCC cells which was significantly associated with presence of EBV. The production of IDO, tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) in human monocyte-derived macrophages (MDMs) was induced by EBV-associated exosomes in vitro. Mechanistically, the retinoic acid-inducible gene I (RIG-I) pathway in MDMs was stimulated by EBV-encoded small RNA-1 (EBER-1) whereas the inhibition of these pathways by BX-795 almost abolished the production of these two cytokines and IDO induction. Also, the EBER-1-activated IDO in MDMs suppressed the proliferation of T lymphocytes and diminished the cytolytic activity of CD8+ T cells.

Conclusion: Exosomes carrying EBER-1 could induce IDO expression in MDMs, considerably aided by an IL-6 and TNF-α-dependent mechanism via the RIG-I signaling pathway, which might create an immunosuppressive microenvironment affecting T-cell immune responses.

Keywords: EBV-encoded small RNA-1 (EBER-1); Epstein-Barr virus (EBV); Exosome carrying EBER-1; Immunosuppressive microenvironment; Indoleamine 2, 3-dioxygenase (IDO); Oral squamous cell carcinomas (OSCCs).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD8-Positive T-Lymphocytes
  • DEAD Box Protein 58 / metabolism
  • Exosomes*
  • Herpesvirus 4, Human
  • Humans
  • Indoleamine-Pyrrole 2,3,-Dioxygenase* / biosynthesis
  • Interleukin-6 / metabolism
  • Macrophages* / enzymology
  • Mouth Neoplasms* / genetics
  • Mouth Neoplasms* / immunology
  • Mouth Neoplasms* / therapy
  • RNA, Viral* / immunology
  • Receptors, Immunologic / metabolism
  • Squamous Cell Carcinoma of Head and Neck* / genetics
  • Squamous Cell Carcinoma of Head and Neck* / immunology
  • Squamous Cell Carcinoma of Head and Neck* / therapy
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Epstein-Barr virus encoded RNA 1
  • IDO1 protein, human
  • IL6 protein, human
  • Indoleamine-Pyrrole 2,3,-Dioxygenase
  • Interleukin-6
  • RNA, Viral
  • Receptors, Immunologic
  • TNF protein, human
  • Tumor Necrosis Factor-alpha
  • RIGI protein, human
  • DEAD Box Protein 58